In The Lancet Respiratory Medicine, Kollengode Ramanathan and colleagues provide excellent recommendations for the use of extracorporeal membrane oxygenation (ECMO) for patients with respiratory failure from acute respiratory distress syndrome (ARDS) secondary to coronavirus disease 2019 (COVID-19). The authors describe pragmatic approaches to the challenges of delivering ECMO to patients with COVID-19, including training health-care personnel, resolving equipment and facilities issues, implementing systems for infection control and personal protection, providing overall support for health-care staff, and mitigating ethical issues. They also address some of the anticipated challenges with local and regional surges in COVID-19 ARDS cases; although there has been an increase in hospitals with the capacity to provide ECMO, the potential demand might exceed the available resources. Furthermore, some health-care systems offer advanced therapies such as ECMO but lack a coordinated local, regional, or national referral protocol.

中文翻译：

---

COVID-19治疗严重的急性呼吸窘迫综合征。

在柳叶刀呼吸内科，Kollengode Ramanathan及其同事为2019年冠状病毒病（COVID-19）继发的急性呼吸窘迫综合征（ARDS）导致呼吸衰竭的患者使用体外膜氧合（ECMO）提供了极好的建议。作者介绍了针对向COVID-19患者提供ECMO的挑战的务实方法，包括培训卫生保健人员，解决设备和设施问题，实施感染控制和个人防护系统，为卫生保健人员提供全面支持以及减轻道德问题。他们还解决了COVID-19 ARDS病例在本地和区域激增的一些预期挑战；尽管提供ECMO能力的医院有所增加，但潜在需求可能会超出可用资源。